Patient-Centered Outcome Measures

Wound chronicity is when any type of wound “stalls” in the proliferative phase. Healthcare professionals worldwide are always looking for the latest and greatest "fix-all" wound dressing. Both clinicians and patients share the challenges faced in battling this common phenomenon. Patients try to bear the substantial clinical, personal, and economic burdens of having a non-healing wound. Faster healing times are essential in decreasing the chances of biofilm formation and infection.

Human Biosciences advanced wound care product options provide clinicians with more practical choices in their "wound care toolbox" versus traditional wound care dressings. This technology offers collagen in its purest form, optimizing a scaffolding system for new cells, debrided devitalized tissue, encourage the formation of new blood vessels, and support tightening wound edges.

Human BioSciences has compiled thousands of field studies on patients with chronic wounds and various etiologies. This data repeatedly validates the value of Medifil® II and SkinTemp® II advanced wound care products. Human BioSciences quality product formulations (particles, sheets, gel) provide an optimal moist wound healing environment while moving non-healing wounds through the healing trajectory.

Results of Retrospective Reviews Utilizing Medifil® II and SkinTemp® II

AuthorLasdayBaxterKollenburgCarterErickson

Status

Hospital

Wound Center

Multiple

PHS*

Home Care

No. of Patients

700

700

1,000

100

100

Wound Type

Chronic

Chronic

Multiple

Multiple

E.B.

Results

Significantly faster healing rate

Significantly faster healing rate

Greater than 95% wound closure rate

Cost effective wound closure

Quality of life enhancement

Results of Prospective Studies Utilizing Medifil® II and SkinTemp® II

Author

Lasday

Lefell

Griswold

Griswold2

Kollenburg

Status

Abstract

Published

Published

Abstract

Abstract

No. of Patients

40

15

8

40

20

Wound Type

Chronic

Post-Mohs

Donor Site

Graft

Surgical

Accelerated Healing Rate

40%

50%

30%

40%

30-40%

The wound care industry's emphasis on outcome-based healing requires advanced solutions. Now, HBS's KollagenTM technology gives clinicians an effective alternative to traditional wound management dressings.


Clinical Research: Comparing the Healing Effectiveness of Wound Care Products

Studies of different wound types compare collagen products to traditional dressings